South Korea
Merck Life Science Breaks Ground on €300 Million Bioprocessing Production Center in Daejeon
Merck Life Science proudly announces the groundbreaking of its new, state-of-the-art Bioprocessing Production Center in Daejeon, representing our largest i...
May 30, 2024 | News
SK Telecom Launches AI-Based Veterinary X-Ray Service 'X Caliber' in Australia
In collaboration with ATX Medical Solutions, SKT launches X Caliber in Australia, which has one of the highest rates of pet ownership in the world ...
May 29, 2024 | News
HanAll Biopharma Secures Exclusive Rights to Cutting-Edge Aging Reprogramming Technology
Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. Collaboration aims t...
May 29, 2024 | News
Vatech Partners with Tygerberg Hospital to Enhance Dental Healthcare in South Africa
Vatech, a global leader in the dental imaging market, is launching a project to improve dental healthcare in South Africa. Vatech announced that it ha...
May 24, 2024 | News
GCCL Introduces First ddPCR Device in South Korea for Enhanced Clinical Trial Sample Analysis
Introduced the first ddPCR device in Korea to provide high-quality clinical trial sample analysis services by increasing test accuracy Differentiate glo...
May 23, 2024 | News
Lunit Completes Acquisition of Volpara Health Technologies, Enhancing AI-Driven Cancer Diagnostics
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, proudly announces the successful completion of i...
May 23, 2024 | News
GC Biopharma and Novel Pharma Receive FDA IND Approval for MPS IIIA Treatment 'GC1130A'
GC Biopharma and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval. With this appr...
May 21, 2024 | News
SN Bioscience’s SNB-101 Receives FDA Fast Track Designation for Breakthrough Small Cell Lung Cancer Treatment
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (...
May 13, 2024 | News
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open ...
May 08, 2024 | News
Sciwind Biosciences and HK inno.N Forge Partnership to Bring New Diabetes Treatment to South Korea
Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation...
May 07, 2024 | News
HanAll Launches Phase III VELOS-4 Trial for Tanfanercept in Dry Eye Treatment
HanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Pha...
May 06, 2024 | News
AriBio Secures EMA Approval for Pivotal POLARIS-AD Alzheimer's Trial, Aligning with FDA and MHRA
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzh...
April 30, 2024 | News
Onconic Therapeutics Gains South Korean Approval for Innovative GERD Treatment JAQBO
Onconic Therapeutics, a leading biotechnology company in Korea, announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQB...
April 26, 2024 | News
Hyundai Bioscience Targets p53 Gene Mutations with Novel Niclosamide-Based Cancer Therapy
The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatm...
April 26, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
